[membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
In an effort to speed new drug approvals in China and to keep and attract drug and device companies, China’s FDA (CFDA) is setting up a regional center for drug evaluation in Shanghai, CCTV reports. In May, CFDA increased the fees to register medi-cines and devices as part of its efforts to fund faster approvals. CFDA is also encouraging pharmaceutical companies to set up their research centers in Shanghai. A timeframe for opening the center was not released.
[/membership]